# Accurate Preoperative and Intraoperative Evaluation Reduces Surgical Costs and Patient Invasiveness in Ventriculoperitoneal Shunt Revision

**Authors:** Marina Takahashi, Taijun Hana, Shota Tanaka, Nobuhito Saito

PMC · DOI: 10.7759/cureus.62334 · 2024-06-13

## TL;DR

Accurate evaluations before and during surgery can reduce costs and invasiveness in VP shunt revisions.

## Contribution

A cost-effective, minimally invasive approach to VP shunt revision is demonstrated through a case study.

## Key findings

- Comprehensive evaluations identified a connective tissue sac as the cause of shunt malfunction.
- Minimally invasive techniques allowed reuse of existing shunt components, reducing costs.
- The approach offers a patient-friendly alternative to traditional revision methods.

## Abstract

The ventriculoperitoneal (VP) shunt is one of the most common surgical procedures in neurosurgery, frequently resulting in malfunctions. Shunt malfunctions, which can include mechanical failure, obstruction, infection, or disconnection, occur in a significant percentage of patients, often necessitating multiple revisions. These revisions can lead to increased healthcare costs due to additional surgeries or treatments. Therefore, addressing the economic impacts of these revisions is crucial.

Our report presents a cost-effective approach to shunt revisions, demonstrated through a case study of an 82-year-old woman with hydrocephalus. Although initially treated with a VP shunt, she required a revision after six years due to shunt malfunction. Through comprehensive preoperative and intraoperative evaluations, including a shuntogram with iodine contrast and meticulous examination, we identified the cause of malfunction as a connective tissue sac blocking the peritoneal catheter. The surgery involved flushing the catheter lumen with saline to confirm the obstruction and careful removal of the obstructive tissue. This accurate diagnosis facilitated a minimally invasive revision, enabling the reuse of existing shunt components and avoiding the need for new devices, thus reducing costs and surgical invasiveness.

Our study serves as a call to action for healthcare providers and surgeons to consider more cost-effective and patient-friendly approaches in managing VP shunt malfunctions, ultimately benefiting both the healthcare system and the patients it serves.

## Linked entities

- **Chemicals:** saline (PubChem CID 5234)
- **Diseases:** hydrocephalus (MONDO:0001150)

## Full-text entities

- **Diseases:** hydrocephalus (MESH:D006849), infection (MESH:D007239)
- **Chemicals:** iodine (MESH:D007455)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11247248/full.md

---
Source: https://tomesphere.com/paper/PMC11247248